Loading...
OTCM
ZIVOW
Market cap20mUSD
Jun 01, Last price  
0.00USD
Name

Zivo Bioscience Inc

Chart & Performance

D1W1MN
OTCM:ZIVOW chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
35.18%
Rev. gr., 5y
42.86%
Revenues
119k
-24.29%
297,295161,340176,90379,14082,725103,8910000000020,0000027,650157,220119,025
Net income
-10m
L-26.09%
-3,541,223-2,250,988-1,813,840-1,416,860-7,122,473-2,731,610-3,248,405-10,095,878680,811-5,789,131-6,059,627-10,038,374-14,635,367-14,667,982-9,655,783-9,396,647-8,745,293-7,777,184-13,384,836-9,892,305
CFO
-3m
L-23.80%
-2,089,257-1,406,740-935,823-1,150,119-1,439,727-1,294,128-1,773,264-2,986,213-2,736,046-2,296,887-2,543,473-4,242,891-5,006,586-3,707,297-2,588,415-6,803,333-7,102,612-5,799,893-4,313,510-3,286,859

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
IPO date
Oct 06, 2000
Employees
8
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT